Mary Crowley Cancer Research Competitors and Similar CompaniesClear all
Mary Crowley Cancer Research's competitors and similar companies include Ontada, DHR Health Institute for Research and Development, Massive Bio, LumaBridge and Alliance for Multispecialty Research.
 DHR Health Institute for Research and Development DHR Health Institute for Research and Development is a clinical research institute. |  LumaBridge LumaBridge (formerly known as Cancer Insight) is a clinical research organization dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies. |  Alliance for Multispecialty Research Alliance for Multispecialty Research (AMR) is a clinical research company. | ||||
Founding Date | Founding Date 1997 | Founding Date 2020 | Founding Date 2019 | Founding Date 2014 | Founding Date 2014 | Founding Date 1994 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | ||||||
Locations | Locations Dallas, US HQ Abilene, US Dallas, US | Locations Atlanta, US HQ | Locations Edinburg, US HQ | Locations New York, US HQ | Locations San Antonio, US HQ San Antonio, US San Antonio, US | Locations Knoxville, US HQ Coral Gables, US El Dorado, US Fort Myers, US Kansas City, US Knoxville, US Las Vegas, US see more |
Employees | Employees 724% decrease | Employees 254 | Employees 11 | Employees 1072% decrease | Employees 442% increase | Employees 4171% increase |
For sources of this data, please see the company profile
View Company Profiles
DHR Health Institute for Research and Development
HQ
Edinburg, US
DHR Health Institute for Research and Development is a clinical research institute.
View company
Massive Bio
HQ
New York, US
Employees
107↓ 2% decrease
Massive Bio is a company that develops AI-driven platforms for cancer treatments.
View companyLumaBridge
HQ
San Antonio, US
Employees
44↑ 2% increase
LumaBridge (formerly known as Cancer Insight) is a clinical research organization dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies.
View company